IDYA
IDEAYA Biosciences, Inc.
+1.21 (+3.21%)38.94USD192K成交股數3.8B市值–本益比(近四季)142.9股價營收比–營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 8.9M | 6.6M | – | 208M | – | – | 0.00-100% | 0.00-100% | 0.00 | 3.9M | 8.0M | 3.5M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 109M | 95.7M | 86.6M | 83.0M | 74.2M | 70.9M | 57.2M | 54.5M | 42.8M | 38.8M | 33.7M | 29.2M |
| 銷售管理費用 | 22.5M | 19.4M | – | 16.4M | 14.6M | 13.5M | 9.7M | 10.4M | 8.2M | 7.1M | 7.9M | 7.1M |
| 營業利益 | −122M+38% | −109M+29% | – | 108M-267% | −88.8M+74% | −84.4M+101% | −66.9M+100% | −64.9M+98% | −51.0M | −41.9M | −33.5M | −32.7M |
| 營業利益率 | -1,380.7% | -1,654.6% | – | 52.2% | – | – | – | – | – | -1,068.4% | -417.1% | -922.9% |
| 稅後淨利 | −112M+45% | −98.5M+37% | – | 119M-326% | −77.5M+96% | −72.2M+113% | −51.8M+89% | −52.8M+89% | −39.6M | −34.0M | −27.4M | −27.9M |
| 淨利率 | -1,269.6% | -1,502.1% | – | 57.4% | – | – | – | – | – | -865.5% | -341.4% | -788.0% |
| 稀釋 EPS | -1.22+39% | -1.11+35% | – | 1.33-296% | -0.88+66% | -0.82+61% | -0.60+30% | -0.68+36% | -0.53 | -0.51 | -0.46 | -0.50 |
| 稀釋股數 | 92.1M | 88.7M | – | 89.7M | 88.5M | 88.4M | 86.2M | 78.0M | 75.1M | 57.5M | 60.0M | 56.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 273M | 158M | 113M | 299M | 115M | 130M | 400M | 183M | 108M | 157M | 152M | 103M |
| 應收帳款 | – | – | – | – | – | – | 20K | 1K | 15K | 18K | 6.7M | 160K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.3B | 1.0B | 1.1B | 1.2B | 1.0B | 1.1B | 1.2B | 974M | 962M | 649M | 533M | 528M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 111M | 93.1M | 86.4M | 93.1M | 81.6M | 76.5M | 59.5M | 42.0M | 26.2M | 28.2M | 24.9M | 25.9M |
| 股東權益 | 1.2B | 937M | 1.0B | 1.1B | 960M | 1.0B | 1.2B | 932M | 935M | 621M | 508M | 502M |
| 負債比 | 8.5% | 9.0% | 7.8% | 7.9% | 7.8% | 7.0% | 4.8% | 4.3% | 2.7% | 4.3% | 4.7% | 4.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −75.2M+25% | – | – | – | −60.3M | – | – | −43.8M | – | – | – |
| 資本支出 | – | 967K | – | – | – | 1.3M | – | – | 1.3M | – | – | – |
| 自由現金流 | – | −76.1M+23% | – | – | – | −61.7M | – | – | −45.1M | – | – | – |
| 折舊攤銷 | 700K | 688K | – | 700K | 700K | 600K | 600K | 600K | 616K | 688K | 600K | 600K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1,160.6% | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 219M | +3024.4% | −114M | -52.0% | -1.28 | −73.5M |
| FY2024 | 7.0M | -70.1% | −274M | -3,921.1% | -3.36 | −251M |
| FY2023 | 23.4M | -54.1% | −113M | -483.0% | -1.96 | −118M |
| FY2022 | 50.9M | +82.3% | −58.7M | -115.2% | -1.42 | −90.6M |
| FY2021 | 27.9M | +43.0% | −49.8M | -178.1% | -1.41 | −58.4M |
| FY2020 | 19.5M | – | −34.5M | -176.6% | -1.40 | 55.0M |
| FY2019 | 0.00 | – | −42.0M | –% | -3.36 | −40.7M |
| FY2018 | – | – | −34.3M | –% | -35.92 | −29.3M |